Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Cancer |
| Start Date: | November 1, 2008 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00813423 |
| Study Type: | Interventional |
| Intervention: | Drug: hydroxychloroquine|Drug: sunitinib malate |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Medicine and Dentistry New Jersey|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other|NIH |
| First Received: | December 20, 2008 |
| End Date: | |
| Last Updated: | December 10, 2009 |
| Last Verified: | December 1, 2009 |